{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":25,"n_cols":5,"rows_kept":25,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[11,2,11,3],[18,2,18,3],[19,2,19,3],[23,2,23,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910300343403321"]
[null,null,"Autore",null,"Cappuzzo Federico"]
[null,null,"Titolo",null,"Guide to Targeted Therapies: EGFR mutations in NSCLC / / by Federico Cappuzzo"]
[null,null,"Pubbl/distr/stampa",null,"Cham : , : Springer International Publishing : , : Imprint : Adis, , 2014"]
[null,null,"ISBN",null,"3-319-03059-0"]
[null,null,"Edizione",null,"[1st ed. 2014.]"]
[null,null,"Descrizione fisica",null,"1 online resource (75 p.)"]
[null,null,"Disciplina",null,"610"]
[{"$nulls":4},"615.1"]
[{"$nulls":4},"616.2"]
[{"$nulls":4},"616994"]
[null,null,"Soggetti",null,"Medicine"]
[{"$nulls":4},"Oncology"]
[{"$nulls":4},"Chemotherapy"]
[{"$nulls":4},"Respiratory organs—Diseases"]
[{"$nulls":4},"Medicine/Public Health, general"]
[{"$nulls":4},"Pharmacotherapy"]
[{"$nulls":4},"Pneumology/Respiratory System"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references at the end of each chapters."]
[null,null,"Nota di contenuto",null,"Introduction -- The Human Epidermal growth factor Receptor (HER) family: structure and function -- Methods for EGFR mutation testing -- Predictive and prognostic implications of EGFR mutations -- EGFR-targeted therapies in non‑small cell lung cancer -- Conclusions."]
[null,null,null,"Sommario/riassunto","Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide."]